The simultaneous emergence of distinct intracranial lesions within the brain presents an intricate challenge for neurosurgeons and oncologists. Typically, arachnoid cysts represent benign, congenital anomalies of the cerebrospinal fluid pathways, frequently located in the middle cranial fossa. In contrast, gliomas constitute the primary parenchymal neoplasms of glial cell lineage. Clinicians seldom observe both conditions together in a single patient. The exceptional coexistence of a glioma and arachnoid cyst across opposite cerebral hemispheres demands thorough diagnostic scrutiny. Because each pathology exerts unique mass effects and pathophysiological stresses, clinicians must evaluate both lesions with utmost precision. Understanding these complex lesions ensures tailored operative planning and optimal neurological preservation.

Dual Intracranial Pathologies: An Unprecedented Clinical Dilemma

Primary brain tumors rarely appear in tandem with developmental cystic malformations. While neurosurgeons occasionally identify arachnoid cysts alongside intracranial aneurysms or subdural hematomas, their contralateral pairing with a glioma represents an uncharted entity. Previous literature extensively describes isolated middle cranial fossa cysts, which usually follow an indolent, asymptomatic course. Similarly, low-grade and high-grade gliomas remain well characterized regarding molecular markers and clinical progression. However, when these two disparate lesions arise simultaneously in opposite temporal lobes, clinical evaluation becomes markedly complex. Physicians cannot immediately assume that a single pathology drives the entire symptom profile. For instance, both temporal gliomas and temporal cysts can trigger focal seizures, altered consciousness, and elevated intracranial pressure. Consequently, surgical teams must determine whether both lesions require simultaneous operative decompression or staged intervention. Overlooking the contralateral cyst might leave the patient vulnerable to persistent intracranial hypertension or mass effect. Conversely, focusing solely on the congenital cyst could delay essential oncological resection. Therefore, recognizing dual intracranial disease enables clinicians to devise comprehensive, balanced treatment paradigms that address both oncological control and fluid homeostasis.

Case Highlights: Ganglioglioma and Oligodendroglioma Variants

Recent evidence highlights two compelling presentations of this dual pathology. The first case involved a 15-year-old male who presented with intractable focal seizures and persistent headaches. Magnetic resonance imaging demonstrated a left temporal mass and a large contralateral right temporal arachnoid cyst. The surgical team successfully performed gross total excision of the neoplasm alongside a cysto-cisternostomy. Histopathological analysis subsequently confirmed a low-grade pilocytic astrocytoma, originally suspected as ganglioglioma. Following intervention, the adolescent achieved complete symptom resolution and an uneventful postoperative recovery. In the second case, a 45-year-old male presented with a similar history of headaches and recurrent seizures. Neuroimaging revealed a right temporal intra-axial neoplasm paired with an expansive contralateral left temporal arachnoid cyst. Surgeons performed a right temporal craniotomy for maximal tumor debulking, coupled with direct surgical decompression of the contralateral cyst. Subsequent histopathological and molecular testing identified an oligodendroglioma, IDH-mutant, WHO grade 2. Remarkably, this patient also experienced an uncomplicated recovery without residual neurological deficits. Both clinical cases demonstrate that early recognition and well-coordinated neurosurgical interventions yield outstanding clinical outcomes. Furthermore, these experiences emphasize the viability of treating both lesions within a unified surgical paradigm.

Pathophysiological Hypotheses Behind Contralateral Lesions

The biological link between concurrent temporal neoplasms and contralateral cysts sparks intriguing scientific speculation. Most authorities consider arachnoid cysts purely congenital anomalies stemming from anomalous splitting of the arachnoid membrane during early embryogenesis. In contrast, gliomagenesis involves somatic genetic mutations, dysregulated signaling cascades, and microenvironmental alterations. Consequently, the simplest explanation posits a purely fortuitous or coincidental association between two separate neurological entities. However, researchers cannot entirely discount an underlying developmental or genetic predisposition. For example, subtle alterations in neural crest migration or early neuroectodermal patterning could conceivably foster both developmental cysts and neoplastic vulnerabilities. Additionally, local biomechanical pressures and altered cerebrospinal fluid hydrodynamics may modulate the surrounding parenchyma over decades. An expanding arachnoid cyst alters regional cerebral blood flow and contralateral tissue compliance. As a result, the contralateral hemisphere might endure persistent shear stress, potentially creating a microenvironment that permits or accelerates neoplastic growth. Furthermore, shared leptomeningeal vascular factors could contribute to synchronous structural changes across both temporal lobes. While definitive molecular proof remains elusive, these hypotheses highlight the need for continued genetic and translational exploration in bilateral neurosurgical presentations.

Advanced Neuroimaging and Differential Diagnostic Precision

Modern neuroimaging serves as the cornerstone for diagnosing concurrent intracranial lesions. Magnetic resonance imaging provides indispensable structural detail that readily separates intra-axial tumors from extra-axial cystic structures. In these complex scenarios, high-resolution T1-weighted, T2-weighted, and fluid-attenuated inversion recovery sequences clearly delineate cyst margins and parenchymal infiltration. Arachnoid cysts typically exhibit complete signal suppression on fluid-attenuated inversion recovery sequences, closely mirroring cerebrospinal fluid without internal diffusion restriction. In contrast, temporal gliomas manifest as hyperintense parenchymal lesions that frequently show heterogeneous architecture or subtle contrast enhancement. Moreover, advanced diffusion-weighted imaging and MR spectroscopy further refine the differential diagnosis by excluding infectious collections or epidermoid cysts. In these patients, functional imaging and tractography also map eloquent speech and memory pathways within the temporal lobes. This detailed mapping is crucial because both temporal lobes harbor essential cognitive networks. Contralateral spatial distortion from a large cyst can displace vital tracts unpredictably. Therefore, comprehensive preoperative neuroradiology prevents catastrophic diagnostic errors. It also ensures that neurosurgeons understand the three-dimensional relationship between the two distinct pathological processes.

Surgical Management of Glioma and Arachnoid Cyst

Formulating an effective operative strategy for dual temporal lesions demands meticulous prioritization. Neurosurgeons must primarily target the life-threatening and oncologically active component. Consequently, the surgical team typically addresses the temporal glioma first to arrest neoplastic expansion and alleviate severe local mass effect. Simultaneously or in a staged fashion, the surgeon must evaluate whether the contralateral arachnoid cyst generates significant mass effect or compromises intracranial compliance. In the reported cases, neurosurgeons performed definitive tumor resection alongside surgical fenestration or decompression of the contralateral cyst. Fenestration techniques, such as microsurgical cysto-cisternostomy, establish permanent communication between the cyst cavity and the basal subarachnoid cisterns. This maneuver effectively reduces intracystic pressure and prevents secondary midline displacement. Furthermore, modern neurosurgical adjuncts, including intraoperative neuronavigation and neuromonitoring, enhance surgical precision during temporal lobectomy. Because neurosurgeons operated on both sides, vigilant hemodynamic management remained paramount throughout the perioperative period. Rapid decompression of bilateral intracranial compartments carries inherent risks, such as subdural hematoma or brain shift. Nevertheless, careful surgical technique and gradual fluid equilibrium safeguarded both patients, resulting in smooth, uneventful postoperative courses.

Long-Term Prognosis and Multidisciplinary Care Pathways

Long-term recovery in patients with dual intracranial pathology depends on rigorous multidisciplinary collaboration. Following uneventful postoperative recovery, patients require coordinated follow-up involving neurosurgeons, neuro-oncologists, neurologists, and radiation therapists. Because both reported patients harbored low-grade gliomas, their overall oncological prognosis remains highly favorable. In cases of IDH-mutant oligodendroglioma or pilocytic astrocytoma, gross total resection substantially prolongs progression-free survival. Nevertheless, medical teams must track potential tumor recurrence through serial contrast-enhanced magnetic resonance imaging at regular intervals. Concurrently, clinicians must monitor the fenestrated arachnoid cyst to verify sustained decompression and exclude refilling. Antiepileptic drug management also represents an essential pillar of long-term care. Since temporal lesions frequently cause epileptogenesis, structured antiepileptic therapy prevents seizure recurrence and promotes cognitive rehabilitation. Furthermore, formal neuropsychological assessments help identify subtle memory or language deficits that might arise after bilateral temporal interventions. When neurosurgical teams integrate oncological surveillance with careful hydrodynamic monitoring, patients achieve robust functional independence. Ultimately, this pioneering case series provides invaluable guidance for managing rare, concurrent intracranial lesions with confidence.

Frequently Asked Questions

How rare is the coexistence of a temporal glioma and a contralateral arachnoid cyst?

This coexistence is exceptionally rare. Medical literature historically records arachnoid cysts alongside aneurysms or vascular malformations. However, this report represents the first documented series demonstrating a unilateral temporal glioma paired with a contralateral temporal arachnoid cyst, presenting novel neurosurgical and diagnostic questions.

What surgical sequence should teams follow for bilateral intracranial lesions?

Surgical teams generally prioritize symptomatic or malignant lesions first. In these patients, neurosurgeons performed direct tumor resection alongside fenestration or decompression of the contralateral cyst. Tailoring intervention to intracranial pressure dynamics, mass effect, and focal neurological deficits ensures optimal safety and recovery.

Can a contralateral arachnoid cyst influence glioma progression or symptoms?

Contralateral arachnoid cysts rarely alter tumor cell biology directly. Nevertheless, they reduce baseline intracranial compliance and exacerbate mass effect. This spatial limitation can precipitate earlier neurological symptoms, such as refractory seizures or severe headaches, necessitating prompt radiological distinction between both lesions.

Disclaimer: This content is for informational and educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Goyal S et al. Concurrent Unilateral Temporal Glioma and Contralateral Temporal Arachnoid Cyst: Case Series and Review of Literature. Neurol India. 2026 May 01. doi: 10.4103/neurol-india.Neurol-India-D-25-00767. PMID: 42087646.
2. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251.
3. Hall S, Smedley A, Sparrow O, Mathad N, Waters R, Chakraborty A, et al. Natural History of Intracranial Arachnoid Cysts. World Neurosurg. 2019;126:e1315-e1320.
4. Mustansir F, Bashir S, Darbar A. Management of Arachnoid Cysts: A Comprehensive Review. Cureus. 2018;10(4):e2458.